Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC
for
Non Small Cell Lung Cancer, NSCLC, Stage III, Nsclc
Location: Stanford CA
Sponsor: Maximilian Diehn
Sex: All
Age: 18+
Code: NCT04585490
Phase3, Recruiting
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
for
Nonsmall Cell Lung Cancer, Performance Status
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT04253964
Phase2, Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer